r s t h s
R等于t等于s
以上为机器翻译结果,长、整句建议使用 人工翻译 。
Merck announced today that the HPS2-THRIVE ( H eart P rotection S tudy 2- T reatment of H DL to R educe the I ncidence of V ascular E vents) study did not meet its primary endpoint.
FORBES: HPS2-THRIVE: No Benefit, Signal Of Harm For Niacin Therapy
Monma Y, Niu K, Iwasaki K, Tomita N, Nakaya N, Hozawa A, Kuriyama S, Takayama S, Seki T, Takeda T, Yaegashi N, Ebihara S, Arai H, Nagatomi R, Tsuji I.
FORBES: Chinese Medicine Infiltrates Scientific Publishing
应用推荐
模块上移
模块下移
不移动